Patients should receive comprehensive education about injection technique, storage requirements, and potential side effects before commencing treatment
Evidence and Research Comparison# IGF-1 LR3 Research# IGF-1 LR3 has become the standard form of IGF-1 used in laboratory research and biomanufacturing: Cell culture : Widely used as a growth factor supplement in serum-free and low-serum culture media, where it provides significantly greater potency per unit mass compared to native IGF-1 Bioprocessing : Applied in manufacturing of biopharmaceuticals and cell-based therapies to support cell growth and viability In vitro pharmacology : Extensive characterization of receptor binding kinetics, downstream signaling, and effects on various cell types including myoblasts, osteoblasts, and neural progenitors Animal studies : Some preclinical data on systemic and local administration effects on muscle growth and recovery in rodent models No human clinical trials have been conducted with IGF-1 LR3
Our efforts have extended beyond reading the scientific literature, too
The compounded versions also did not use the same auto-injectors as the branded versions
The dosing schedule of Victoza is as follows: Week 1 (starting dose) : 0.6 mg per day (to improve GI tolerability for at least 1 week) Week 2: 1.2 mg per day (for at least 1 week) Week 3: 1.8 mg per day for further glycemic control or when lower doses are ineffective
Bang S, Choi SH, Jeong SM